Diet and neurocognition: Review of evidence and methodological considerations

Current Aging Science

Volumn 3, Issue 1, 2010, Pages 57-66

  Smith, Patrick J ^a   Blumenthal, James A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Caloric restriction; Cognitive performance; DASH diet; Fatty acids; Mediterranean diet; Neurocognition; Vitamin B

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CYANOCOBALAMIN; FISH OIL; FOLIC ACID; PYRIDOXINE;

ALZHEIMER DISEASE; ARTICLE; CALORIC RESTRICTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIETARY INTAKE; FAT INTAKE; FOLLOW UP; FRUIT; HUMAN; INCIDENCE; MEDITERRANEAN DIET; METHODOLOGY; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; VEGETABLE;

ANTIOXIDANTS; CALORIC RESTRICTION; COGNITION; COGNITION DISORDERS; DIET; FATTY ACIDS; HUMANS; VITAMINS;

EID: 77953736212     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811003010057     Document Type: Article

References (93)

1. Del Parigi A, Panza F, Capurso C and Solfrizzi V. Nutritional factors, cognitive decline, and dementia. Brain Res Bull 2006; 69: 1-19.
2. Luchsinger JA and Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol 2004; 3: 579-8.
3. Essink-Bot ML, Pereira J, Packer C, Schwarzinger M and Burstrom K. Cross-national comparability of burden of disease estimates: the European disability weights project. Bull World Health Organ 2002; 80: 644-52.
4. Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR and Duttagupta S. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Am J Manag Care 2001; 7: 809-18.
5. Haan MN and Wallace R. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health 2004; 25: 1-24.
6. Boudrault C, Bazinet RP and Ma DW. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem 2009; 20: 1-10.
7. Kalmijn S, Feskens EJ, Launer LJ and Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997; 145: 33-41.
8. van Gelder BM, Tijhuis M, Kalmijn S and Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the zutphen elderly study. Am J Clin Nutr 2007; 85: 1142-7.
9. Capurso A, Solfrizzi V, Panza F, Torres F, Mastroianni F, Grassi A, et al. The role of olive oil in Mediterranean diet: Unsaturated fatty acids protect from age-related cognitive decline. Atherosclerosis 1997; 135: S3.
10. Heude B, Ducimetiere P and Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes--the eva study. Am J Clin Nutr 2003; 77: 803-08.
11. Dullemeijer C, Durga J, Brouwer IA, van de RO, Kok FJ, Brummer RJ, et al. n-3 fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr 2007; 86: 1479-5.
12. Morris MC, Evans DA, Bienias JL, Tangney CC and Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004; 62: 1573-9.
13. Beydoun MA, Kaufman JS, Satia JA, Rosamond W and Folsom AR. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis risk in communities study. Am J Clin Nutr 2007; 85: 1103-11.
14. Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D and Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004; 62: 275-80.
15. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF and Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ 2002; 325: 932-3.
16. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60: 940-6.
17. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 2003; 60: 194-200.
18. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006; 63: 1545-50.
19. Devore EE, Grodstein F, van Rooij FJ, Hofman A, Rosner B, Stampfer MJ, et al. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 2009; 90: 170-6.
20. Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Torres F, Rizzo C, et al. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging 2006; 27: 1694-704.
21. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, et al. Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology 2002; 59: 1915-21.
22. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N and Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol 2009; 66: 216-25.
23. Yehuda S, Rabinovtz S, Carasso RL and Mostofsky DI. Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci 1996; 87: 141-9.
24. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, et al. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychophar-macol Biol Psychiatry 2008; 32: 1538-44.
25. Terano T, Fujishiro S, Ban T, Yamamoto K, Tanaka T, Noguchi Y, et al. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 1999; 34(Suppl): S345-S6.
26. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 2006; 56: 159-64.
27. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008; 71: 430-8.
28. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized doubleblind trial. Arch Neurol 2006; 63: 1402-8.
29. Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, et al. Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms. Ageing Res Rev 2009. [Epub ahead of print].
30. Balk EM, Raman G, Tatsioni A, Chung M, Lau J and Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 2007; 167: 21-30.
31. Scarmeas N, Stern Y, Tang MX, Mayeux R and Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006; 59: 912-21.
32. Scarmeas N, Stern Y, Mayeux R and Luchsinger JA. Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 2006; 63: 1709-17.
33. Feart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009; 302: 638-48.
34. Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009; 302: 627-37.
35. Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995; 9: 526-33.
36. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
37. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G and Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006; 65: 631-41.
38. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, et al. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997; 66: 803-9.
39. Joshipura KJ, Ascherio A, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999; 282: 1233-9.
40. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, et al. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997; 66: 803-809.
41. Morris MC, Evans DA, Tangney CC, Bienias JL and Wilson RS. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 2006; 67: 1370-6.
42. La RA, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY and Garry PJ. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 1997; 65: 20-9.
43. Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Szekely CA, Wengreen H, et al. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the cache county study. Alzheimers Dement 2008; 4: 223-7.
44. Morris MC, Evans DA, Bienias JL, Tangney CC and Wilson RS. Vitamin E and cognitive decline in older persons. Arch Neurol 2002; 59: 1125-32.
45. Wengreen HJ, Munger RG, Corcoran CD, Zandi P, Hayden KM, Fotuhi M, et al. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging 2007; 11: 230-7.
46. Masaki KH, Losonczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000; 54: 1265-72.
47. Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004; 61: 82-8.
48. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287: 3223-9.
49. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P and Dartigues JF. Intake of flavonoids and risk of dementia. Eur J Epidemiol 2000; 16: 357-63.
50. Letenneur L, Proust-Lima C, Le GA, Dartigues JF and Barberger-Gateau P. Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 2007; 165: 1364-71.
51. Youdim KA, Shukitt-Hale B and Joseph JA. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 2004; 37: 1683-93.
52. Isaac MG, Quinn R and Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2008; CD002854.
53. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379-88.
54. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study. N Engl J Med 1997; 336: 1216-22.
55. Hayden KM, Welsh-Bohmer KA, Wengreen HJ, Zandi PP, Lyketsos CG and Breitner JC. Risk of mortality with vitamin E supplements: the cache county study. Am J Med 2007; 120: 180-4.
56. Van DK and Sano M. The impact of nutrition on cognition in the elderly. Neurochem Res 2007; 32: 893-904.
57. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2003; 2: 425-8.
58. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B and Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 2001; 56: 1188-94.
59. Morris MC, Evans DA, Schneider JA, Tangney CC, Bienias JL and Aggarwal NT. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J Alzheimers Dis 2006; 9: 435-43.
60. Luchsinger JA, Tang MX, Miller J, Green R and Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007; 64: 86-92.
61. Balk EM, Raman G, Tatsioni A, Chung M, Lau J and Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 2007; 167: 21-30.
62. Aisen PS, Schneider LS, Sano M, az-Arrastia R, van Dyck CH, Weiner MF, et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 2008; 300: 1774-83.
63. Malouf R and Grimley EJ. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008; CD004514.
64. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007; 369: 208-16.
65. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI and Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354: 2764-72.
66. Connelly PJ, Prentice NP, Cousland G and Bonham J. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychiatry 2008; 23: 155-60.
67. Malouf R and Areosa SA. Vitamin B12 for cognition. Cochrane Database Syst Rev 2003; CD004326.
68. Malouf R and Grimley EJ. The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 2003; CD004393.
69. Kang JH, Cook N, Manson J, Buring JE, Albert CM and Grodstein F. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 2008; 88: 1602-10.
70. Martin CK, Anton SD, Han H, York-Crowe E, Redman LM, Ravussin E, et al. Examination of cognitive function during six months of calorie restriction: results of a randomized controlled trial. Rejuv Res 2007; 10: 179-90.
71. Gillette-Guyonnet S and Vellas B. Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care 2008; 11: 686-92.
72. Luchsinger JA, Tang MX, Shea S and Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol 2002; 59: 1258-63.
73. Willcox BJ, Willcox DC, Todoriki H, Fujiyoshi A, Yano K, He Q, et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann NY Acad Sci 2007; 1114: 434-55.
74. Witte AV, Fobker M, Gellner R, Knecht S and Floel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA 2009; 106: 1255-60.
75. Bryan J and Tiggemann M. The effect of weight-loss dieting on cognitive performance and psychological well-being in overweight women. Appetite 2001; 36: 147-56.
76. Halyburton AK, Brinkworth GD, Wilson CJ, Noakes M, Buckley JD, Keogh JB, et al. Low- and high-carbohydrate weight-loss diets have similar effects on mood but not cognitive performance. Am J Clin Nutr 2007; 86: 580-7.
77. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, et al. Association of vitamin D deficiency with cognitive impairment in older women. Cross-sectional study. Neurology 2009; [Epub ahead of print]
78. Oudshoorn C, Mattace-Raso FU, van de Velde N, Colin EM and van der Cammen TJ. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25: 539-43.
79. Buell JS, Scott TM, wson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009; 64: 888-95.
80. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009; 16: 1083-9.
81. Buell JS and wson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing Decline? Mol Aspects Med 2008; 29: 415-22.
82. Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Lorusso M, et al. Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J Alzheimers Dis 2009; 17: 7-31.
83. Anstey KJ, Mack HA and Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009; 17: 542-55.
84. Peters R, Peters J, Warner J, Beckett N and Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 2008; 37: 505-12.
85. Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Del PA, Baldassarre G, et al. Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology 2007; 68: 1790-9.
86. Collins MA, Neafsey EJ, Mukamal KJ, Gray MO, Parks DA, Das DK, et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 2009; 33: 206-19.
87. Verbaten MN. Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not? Hum Psychopharmacol 2009; 24: 199-205.
88. Coley N, Andrieu S, Gardette V, Gillette-Guyonnet S, Sanz C, Vellas B, et al. Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev 2008; 30: 35-66.
89. Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, et al. Methodological issues in primary prevention trials for neurodegenerative dementia. J Alzheimers Dis 2009; 16: 235-70.
90. Stubbs RJ, Johnstone AM, O'Reilly LM and Poppitt SD. Methodological issues relating to the measurement of food, energy and nutrient intake in human laboratory-based studies. Proc Nutr Soc 1998; 57: 357-72.
91. Barnes DE, Whitmer RA and Yaffe K. Physical activity and dementia: the need for prevention trials. Exerc Sport Sci Rev 2007; 35: 24-9.
92. Duron E and Hanon O. Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis 2008; 101: 181-9.
93. Duron E and Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 2008; 4: 363-81.